Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]

13388 reported adverse events

Drugs of this class: ELOSULFASE ALFA GALSULFASE IDURSULFASE LARONIDASE TIVIDENOFUSP ALFA-EKNM

These side effects are most commonly reported by patients taking drugs of the Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] class:

# Side effect Count
0 PYREXIA 2297
1 COUGH 1082
2 PNEUMONIA 1024
3 DYSPNOEA 894
4 VOMITING 853
5 MALAISE 742
6 HEADACHE 599
7 PRODUCT DOSE OMISSION ISSUE 594
8 PAIN 590
9 FATIGUE 587
See all common reactions for Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]

Drugs of the Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URINARY GLYCOSAMINOGLYCANS INCREASED 26 0.9630
1 MUCOPOLYSACCHARIDOSIS II 39 0.8298
2 MUCOPOLYSACCHARIDOSIS I 25 0.6944
3 CERVICAL CORD COMPRESSION 91 0.2507
4 EAR TUBE INSERTION 54 0.1824
5 TRACHEOSTOMY MALFUNCTION 34 0.1643
6 SPINAL DECOMPRESSION 59 0.1398
7 ADENOIDAL DISORDER 36 0.1385
8 ADENOIDAL HYPERTROPHY 38 0.1005
9 BODY HEIGHT INCREASED 47 0.0959
See all enriched reactions for Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]